|
COVID-19 : ¹é½Å/Ä¡·áÁ¦ ÆÄÀÌÇÁ¶óÀÎ ¹× Áø´Ü Ãֽе¿Çâ - NewsLetter
BIS Research on COVID-19: An Indication Toward Solutions (Monthly Snapshot Report)
|
¸®¼Ä¡»ç |
BIS Research Inc.
|
¹ßÇàÁ¤º¸ |
12 ȸ/³â |
»óǰÄÚµå |
953755 |
ÆäÀÌÁö Á¤º¸ |
¿µ¹®
|
COVID-19 : ¹é½Å/Ä¡·áÁ¦ ÆÄÀÌÇÁ¶óÀÎ ¹× Áø´Ü Ãֽе¿Çâ - NewsLetter
BIS Research on COVID-19: An Indication Toward Solutions (Monthly Snapshot Report)
|
¹ßÇàÁ¤º¸ : 12 ȸ/³â | ÆäÀÌÁö Á¤º¸ : ¿µ¹® |
|
|
¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹®¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù. º» NewsLetter´Â COVID-19ÀÇ Áø´Ü, Ä¡·á, ¹é½Å °³¹ß¿¡ °üÇÑ End-to-EndÀÇ ½Ã±âÀûÀýÇÑ ¸®ºä¿Í ÃֽŠÁ¤º¸¸¦ ¸Å¿ù ÀüÇØµå¸³´Ï´Ù.
º» NewsLetterÀÇ Á¦°ø ³»¿ë
- ¹é½Å°ú Ä¡·á¹ý °³¹ß °úÁ¤ÀÇ ºê·¹ÀÌÅ©½º·ç
- COVID-19°¡ ¼¼°èÀÇ ºñÁö´Ï½º ½Ã³ª¸®¿À¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ °üÇÑ ½Å·Ú¼º ³ôÀº Á¤º¸
- COVID-19ÀÇ ¹é½ÅÀ̳ª Ä¡·áÁ¦¸¦ °³¹ßÇϰí ÀÖ´Â ÁÖ¿ä ±â¾÷ Á¤º¸
º» NewsLetterÀÇ ÀÌÁ¡
- COVID-19¿¡ °üÇÑ ÃֽŠÁ¤º¸¸¦ ¸Å¿ù ÀÔ¼öÇÒ ¼ö ÀÖ½À´Ï´Ù.
- BIS Research º¸°í¼¿¡ °ÔÀçµÈ 100°³ ÀÌ»óÀÇ ÀÇ·á °ü·Ã º¸°í¼ ÁÖ¿ä ¿ä¾à°ú ±â¾÷ °³¿ä¿¡ ¾×¼¼½º ÇÒ ¼ö ÀÖ½À´Ï´Ù.
- BIS Research°¡ ¹ßÇàÇÏ´Â º¸°í¼¸¦ 20% ÇÒÀÎ ÇýÅÃÀ¸·Î ±¸ÀÔÇÒ ¼ö ÀÖ½À´Ï´Ù.
KSM 20.08.27
The report snapshot covers end-to-end timely review and updates for your business in the times of COVID-19, covering diagnostics, treatments, and vaccine development.
Combat the Pandemic's Impact on Your Business and Growth
BIS COVID - 19 Monthly Snapshot:
- Available through monthly subscription
- Insights to stay updated during the pandemic.
The single, monthly edition of our report snapshot covers:
- breakthrough in the course of development of vaccines and treatment options during the pandemic
- credible source of information related to impact of the COVID-19 on the global business scenario and relevant reports offered by BIS Research
- key players developing vaccine and drug for COVID-19
Key Benefits
- Stock prices of many pharma companies has risen by 20%-30% in the April 2020 as compared to Q3 FY20 period.
- Operation Warp Speed (OWS) launched by The U.S. government for vaccine development
- 116% Growth (Highest) Expected in AI-Enabled Solutions for Analysis of CT Images
- 83.54% Growth (Highest) Expected in Europe in AIEnabled Medical Imaging Solutions Market Revenue in FY2020
|

|
µ¿¹° Àå°Ç° ½ÃÀå ¿¹Ãø(-2027³â) : ÷°¡¹°º°, °¡Ãະ, À¯·¡º°, Çüź°, Áö¿ªº°- COVID-19ÀÇ ´©Àû ¿µÇâ
¼¼°èÀÇ 1Â÷ Áø·áÀÇ ½ÃÀå : ȯ°æº°, ¼ºñ½ºº°, Áö¿ªº° ¿¹Ãø(-2027³â) - COVID-19ÀÇ ´©Àû ¿µÇâ
¼¼°èÀÇ °Ô³ë¹Í½º¿ë ÀΰøÁö´É(AI) ½ÃÀå ¿¹Ãø(-2027³â) : Á¦Ç°º°, ±â¼úº°, ±â´Éº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° - COVID-19ÀÇ ´©Àû ¿µÇâ
¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ ¼öŹÁ¦Á¶ ½ÃÀå : Á¦Ç°º°, À¯·¡º°, °è¾à À¯Çüº°, ¼ºñ½ºº°, »ç¾÷ ±Ô¸ðº°, Ä¡·á ¿ëµµº°, Áö¿ªº° ¿¹Ãø(-2027³â) - COVID-19ÀÇ ´©Àû ¿µÇâ
¼¼°èÀÇ ºñÈļº ¹× ÄÉ·ÎÀ̵å ÈäÅÍ Ä¡·á ½ÃÀå : ¹ÝÈç Á¾·ùº°(ºñÈļº ¹ÝÈç, ÄÉ·ÎÀÌµå ¹ÝÈç), Á¦Ç°º°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°(¾Æ¸Þ¸®Ä«, ¾Æ½Ã¾ÆÅÂÆò¾ç, À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«) ¿¹Ãø(-2027³â) - COVID-19ÀÇ ´©Àû ¿µÇâ
¼¼°èÀÇ »ý¹°Á¦Á¦ ¼öŹ Á¦Á¶ ½ÃÀå : Á¦Ç°º°, Ç÷§Æûº°, Ä¡·á ¿µ¿ªº°, Áö¿ªº° - COVID-19ÀÇ ´©Àû ¿µÇâ
¼¼°èÀÇ ¼öÀÇ ¼ºñ½º ½ÃÀå(2022-2030³â) : ½ÃÀå ±Ô¸ð(¼ºñ½º Á¾·ù, µ¿¹° Á¾·ùº°), Áö¿ªÀû Àü¸Á, COVID-19ÀÇ ¿µÇâ, ¿ëµµ ÀáÀ缺, ½ÃÀå Á¡À¯À², ¿¹Ãø
¼¼°èÀÇ ¾ç¸· Á¦Ç° ½ÃÀå : Á¾·ùº°(¾ç¸·, ¾ç¸· Çöʾ×), ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ¿¹Ãø(-2027³â) - COVID-19ÀÇ ´©Àû ¿µÇâ
¼¼°èÀÇ ¿ÕÁø ½ÃÀå : ¼ºñ½ºº°(¸¸¼ºÁúȯ Ä¡·á °ü¸®, À̵¿½Ä ÀÓ»ó °Ë»ç, ¿¹¹æ ÀÇ·á), ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°(¾Æ¸Þ¸®Ä«, ¾Æ½Ã¾ÆÅÂÆò¾ç, À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«) ¿¹Ãø(-2027³â) - COVID-19ÀÇ ´©Àû ¿µÇâ
¼¼°èÀÇ ÀÓ»ó½ÃÇè ¸ÅĪ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : Àü°³º°(Ŭ¶ó¿ìµå ¹× À¥ ±â¹Ý, ¿ÂÇÁ·¹¹Ì½º), ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°(¾Æ¸Þ¸®Ä«, ¾Æ½Ã¾ÆÅÂÆò¾ç, À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«) ¿¹Ãø(-2027³â) - COVID-19ÀÇ ´©Àû ¿µÇâ
|